Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Latest form 20-F annual reports for Novo Nordisk CIK: 0000353278The 20-F is a 10-K equivalent for non-US companies, as a foreight company Novo Nordisk only files 20-F reports
Language: English